Safer brain scans? study tests MRI without risky dye for tumor detection
NCT ID NCT04113408
Summary
This study tested whether new MRI scanning techniques could detect meningioma brain tumors without using gadolinium contrast dye. Researchers compared standard contrast-enhanced MRI scans with experimental non-contrast scans in 315 adults undergoing tumor screening or monitoring. The goal was to validate safer scanning methods that avoid potential long-term risks from repeated contrast dye injections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondation ophtalmique Adolphe de Rothschild
Paris, Paris, 75019, France
Conditions
Explore the condition pages connected to this study.